Category: Cardiology

  • HFpEF: overview of management of heart failure with preserved ejection fraction

    Suggested reading: Up-to-date Overview:

  • HFrEF: overview of management of heart failure with reduced ejection fraction

    Suggested reading: Up-to-date Overview:

  • EKG: Tachycardia

    EKG: Tachycardia

    Steps in evaluation Step one: verify tachycardia and hemodynamic stability. If unstable refer to ACLS algorithms please.  Step two: determine whether the QRS is narrow complex or wide complex Step three: if narrow complex determine whether irregular or regular rhythm Step four: if wide complex tachycardia, determine whether monomorphic or polymorphic Algorithm for the…

  • How to read EKGs

    Overview of Dubin’s Method for Reading EKG’s 1. RATE (pp. 65-96) Estimate using “300, 150, 100…” Bradycardia: rate = cycles/6 sec. strip × 10 2. RHYTHM (pp. 97-202) Identify basic rhythm, scan for prematurity, pauses, irregularity, abnormal waves. Check for: 3. AXIS (pp. 203-242) QRS above or below baseline for Axis Quadrant (Normal vs. R. or L. Axis Deviation).…

  • EKG: Bradycardia

    EKG: Bradycardia

    Here is the algorithm for bradycardia

  • Heart murmurs

    Murmur location Systolic vs diastolic and Murmur description Murmur grade (Levine’s grading) How to approach heart murmurs

  • Edema

    Edema evaluation Attendance requirements: Please see the “Guidelines” section. Objectives: Know the differential for this condition Know how to approach a patient with this condition. Know basic signs, symptoms, and treatment of other medical conditions in the differential. Required reading: Harrison’s chapter on Edema. Also, review other “student slides” below. Know the differential and work-up…

  • Dyspnea

    Dyspnea

  • Chest Pain

    Chest pain

  • Prescribing of Fibrates

    Comment: In large trials published in 2005 and 2010, fenofibrate did not improve cardiovascular outcomes significantly in patients with type 2 diabetes (JW Cardiol Jan 5 2006 and Mar 14 2010). Although gemfibrozil lowered rates of cardiovascular endpoints in older trials involving high-risk nondiabetic patients conducted largely before the statin era — for example, the…